sorbitol has been researched along with meglumine antimoniate in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (84.21) | 18.7374 |
1990's | 3 (15.79) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goerttler, E; Krutmann, J; Rzany, B; Schöpf, E | 1 |
Dorea, JG; Holzbecher, J; Merchan-Hamann, E; Ryan, DE | 2 |
Arana, BA; Arana, FE; Castillo, AL; de Mérida, AM; Navin, TR; Pozuelos, JL | 1 |
Jackson, JE; Tally, JD; Tang, DB | 1 |
Coutellier, P; Delgrange, B | 1 |
de Vásquez, AM; Johnson, CM; Narvaez, E; Paz, HM; Sáenz, RE | 1 |
Chulay, JD; Fleckenstein, L; Smith, DH | 1 |
Bloom, B; Castellanos, PL; Castes, M; Convit, J; Garcia, L; Pinardi, ME; Rondon, A; Ulrich, M | 1 |
Chapman, WL; Hanson, WL; White, MR | 1 |
Kumar, PV; Sadeghi, E; Torabi, S | 1 |
de la Cruz Amorós, E; Lambruschini Ferri, N; Rodríguez Miguélez, JM; Torres Simón, JM | 1 |
Hiçsönmez, G; Jama, H; Ozsoylu, S | 1 |
Alvar, J; González-Lahoz, JM; Polo, RM; Verdejo, J | 1 |
Dumon, H; Franck, J; Gambarelli, F | 1 |
el-On, J; Kernbaum, S; Rubinstein, N; Schnur, LF | 1 |
Costa, JM; Dorea, JG; Holzbecher, J; Marsden, PD; Ryan, DE | 1 |
Barreto, AC; Cuba, CC; Guerra, M; Magalhâes, A; Marsden, PD; Rocha, RA; Sampaio, RN | 1 |
Avila, JL; Biondo, F; Convit, J; Monzón, H | 1 |
2 trial(s) available for sorbitol and meglumine antimoniate
Article | Year |
---|---|
Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala.
Topics: Adult; Animals; Antimony; Antiprotozoal Agents; Follow-Up Studies; Guatemala; Hot Temperature; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Military Personnel; Organometallic Compounds; Radio Waves; Randomized Controlled Trials as Topic; Sorbitol | 1990 |
Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis.
Topics: Adolescent; Adult; Antibodies; Antigens, Protozoan; Antiprotozoal Agents; Child; Clinical Trials as Topic; Female; Humans; Immunotherapy; Leishmania mexicana; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mycobacterium bovis; Organometallic Compounds; Random Allocation; Skin Tests; Sorbitol; Vaccination | 1987 |
17 other study(ies) available for sorbitol and meglumine antimoniate
Article | Year |
---|---|
[Cutaneous leishmaniasis: treatment with cryotherapy and intramuscular injections of meglumine antimonate (glucantime)].
Topics: Adult; Combined Modality Therapy; Cryosurgery; Female; Humans; Injections, Intramuscular; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Otitis Externa; Sorbitol | 1990 |
Retention of antimony in skin biopsies of leishmaniasis patients after treatment with N-methylglucamine antimoniate.
Topics: Adolescent; Adult; Aged; Antimony; Biopsy; Child; Double-Blind Method; Drug Administration Schedule; Humans; Injections, Intravenous; Leishmaniasis; Meglumine; Meglumine Antimoniate; Middle Aged; Neutron Activation Analysis; Organometallic Compounds; Random Allocation; Skin; Sorbitol | 1990 |
An in vitro micromethod for drug sensitivity testing of Leishmania.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Culture Media; Gluconates; Humans; Least-Squares Analysis; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Sorbitol; Time Factors | 1989 |
[Kala-azar. Apropos of a case report in a Belgian woman].
Topics: Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sorbitol | 1989 |
Retention of antimony in hair during leishmaniasis treatment.
Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Child; Drug Administration Schedule; Hair; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1989 |
[Evaluation of the effectiveness and toxicity of pentostam and glucantime in the treatment of cutaneous leishmaniasis].
Topics: Adult; Antimony Sodium Gluconate; Drug Evaluation; Female; Gluconates; Humans; Immunologic Techniques; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Random Allocation; Sorbitol | 1987 |
Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate.
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Gluconates; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1988 |
Chemotherapy of experimental visceral leishmaniasis in the opossum.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Body Weight; Female; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Opossums; Organ Size; Organometallic Compounds; Sorbitol; Spleen | 1989 |
Kala azar with disseminated dermal leishmaniasis.
Topics: Adolescent; Antiprotozoal Agents; Biopsy; Child; Female; Humans; Iran; Leishmaniasis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin; Sorbitol | 1989 |
[Glucantime and allopurinol in the treatment of persistent infantile visceral leishmaniasis].
Topics: Allopurinol; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunologic Tests; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1988 |
Severe leucopenia during treatment of visceral leishmaniasis.
Topics: Antimony; Antiprotozoal Agents; Child; Child, Preschool; Humans; Infant; Leishmaniasis, Visceral; Leukocyte Count; Leukopenia; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1988 |
Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
Topics: Antimony; Antiprotozoal Agents; Humans; Immune Tolerance; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1988 |
[Sensitivity of Leishmania spp. to antimony derivatives. Use of mouse peritoneal macrophages].
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Leishmania; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Peritoneal Cavity; Sorbitol | 1987 |
In vitro and in vivo anti-leishmanial activity of chlorpromazine alone and combined with N-meglumine antimonate.
Topics: Animals; Antiprotozoal Agents; Chlorpromazine; Drug Therapy, Combination; Leishmania; Leishmaniasis; Macrophages; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Organometallic Compounds; Sorbitol; Spleen | 1986 |
Antimony accumulation in hair during treatment of leishmaniasis.
Topics: Antimony; Brazil; Hair; Humans; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Neutron Activation Analysis; Organometallic Compounds; Retrospective Studies; Sorbitol | 1987 |
Apparent Glucantime failure in five patients with mucocutaneous leishmaniasis.
Topics: Amphotericin B; Antigens; Antimony; Brazil; Female; Fluorescent Antibody Technique; Humans; Leishmania; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sorbitol | 1980 |
Cutaneous leishmaniasis in mice: resistance to glucan immunotherapy, either alone or combined with chemotherapy.
Topics: Animals; Antimony; Dose-Response Relationship, Immunologic; Female; Glucans; Immunotherapy; Leishmaniasis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C57BL; Mononuclear Phagocyte System; Organometallic Compounds; Sorbitol | 1982 |